Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories

The Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories is a forecasted federal funding opportunity administered by the National Institutes of Health within the U.S. Department of Health and Human Services, specifically through the National Institute of Allergy and Infectious Diseases. This initiative reflects a continued federal priority to strengthen national infrastructure for infectious disease research and public health preparedness. Regional Biocontainment Laboratories have been designated by Congress as a priority area for NIAID, underscoring their importance in supporting research and response efforts related to emerging and existing infectious diseases. The primary purpose of this funding opportunity is to provide sustained, multi-year support for the operations, maintenance, and workforce development associated with Regional Biocontainment Laboratories. These laboratories operate at biosafety level 2 and 3 and are essential for conducting safe and controlled research on infectious agents. The funding is intended to ensure that these facilities remain fully operational, compliant with biosafety standards, and capable of responding rapidly to public health emergencies. In addition to infrastructure support, the program emphasizes workforce development through specialized training programs designed to maintain a skilled and capable biosafety workforce across the United States. Funding under this program will support a range of allowable activities, including facility maintenance, operational costs, staffing, and training programs specific to biocontainment practices. The initiative aims to preserve the readiness and technical capability of these laboratories, ensuring they can support research during both routine periods and emergency response scenarios. There is no indication of cost sharing or matching requirements, which suggests that the federal government intends to fully fund the supported activities within the defined scope. Eligibility for this opportunity is limited to a specific group of institutions, reflecting its designation as a limited competition. Eligible applicants include certain public and private institutions of higher education that are already associated with Regional Biocontainment Laboratories. These include institutions such as the University of Alabama at Birmingham, Tulane University, Duke University, Rutgers University, and several others explicitly named in the eligibility section. This restriction ensures that funding is directed to organizations with existing infrastructure and demonstrated capacity to manage high-level biocontainment facilities. The application process will follow standard NIH procedures for cooperative agreements, including submission through official federal grant systems and adherence to NIH guidelines. Applications will undergo a formal peer review process in which proposals are evaluated based on scientific merit and alignment with program objectives. Only those applications deemed meritorious through this review process will be considered for funding. While specific application components are not detailed in the forecast, applicants can expect requirements typical of NIH submissions, such as detailed project plans, budgets, and descriptions of facilities and personnel. The opportunity is currently in a forecast stage, with an estimated posting date of July 2, 2027, and an anticipated application deadline of September 30, 2027. Awards are expected to be made by August 1, 2028, with project start dates aligned to the same timeline. The program anticipates approximately twelve awards with a total program funding level of 36,000,000 dollars. Interested applicants are encouraged to monitor updates and prepare in advance of the official release. Questions regarding the program may be directed to the NIAID Division of Microbiology and Infectious Diseases via the provided program email contact.